Sanofi launches its first Digital Accelerator driven by new talent and focused on growth
Paris, June 8, 2022
. Sanofi announces the launch of its first Digital Accelerator, the purpose of which is to help the company realize its ambition to be among the leaders in digital health. This Accelerator aims to develop products and solutions in support of Sanofi’s mission to transform the practice of medicine through digital, data and artificial intelligence (AI). Based in Paris, it already relies on a team of more than 75 specialists from all over the world and will continue to recruit top-notch talent, specialized in
product management
Development
full-stack
and the
data science
.
A place of diversity, the Digital Accelerator includes teams from both internal mobility and external recruitment and is supported by the launch of a
Accelerator Academy
dedicated to improving employee skills. A partnership with the international non-profit organization
Women In Tech
was also established to fill the gap of women in the digital sector. The Digital Accelerator will have 300 employees within two years in the most relevant geographies to support Sanofi’s global digital strategy, attract new talent and further embed agile working methods into the corporate culture.
This Accelerator initially aims to meet the unmet needs of patients suffering from atopic dermatitis in France, Italy and Spain. His team is already working to develop an integrated platform and data tools to better engage healthcare professionals and educate them and their patients about the disease and available treatment options.
Arnaud-Robert
Executive Vice President and Chief Digital Officer, Sanofi
“Sanofi’s digital transformation is as much about cultural and business transformation as it is about technology. The Digital Accelerator will help us democratize the use of data, develop agility at all levels of the organization and accelerate innovation for patients and healthcare professionals – quickly and at scale. This investment in the Digital Accelerator once again illustrates our desire to transform the practice of medicine and provide better solutions to patients. »
Since the presentation of its new global digital strategy in 2021, Sanofi has simultaneously endeavored to put in place solid foundations in terms of digital tools and data, to create commercial value, to develop the acquisition of new skills and promote a culture of digital and data through the training of more than 16,000 of its employees. More than 300 new talents have also joined Sanofi over the past 18 months in France, Spain, the United States and Canada to strengthen the teams specializing in digital, data and cybersecurity.
The ongoing digital transformation has already yielded important results, in particular:
accelerating the discovery of new targets through artificial intelligence;
the acceleration of image analysis in R&D thanks to artificial intelligence (which is done in a few minutes compared to several weeks previously);
improving the efficiency of clinical trials through the use of real-life data in order to reduce the number of patients to be recruited and by allowing participants to transmit their data and digital biomarkers remotely;
accelerating access to clinical reports for health authorities by making data available in the cloud and natural language processing;
the strengthening of exchanges with healthcare professionals thanks to an integrated CRM and omnichannel solution, already deployed in 18 countries;
optimizing advertising and promotion spend across multiple markets and across multiple products through data integration and artificial intelligence;
digitizing manufacturing processes with modern solutions and improving supply chain performance with predictive AI.
By 2025, Sanofi’s cutting-edge digital health platform will deliver new digital offerings, empower patients and healthcare professionals with new digital experiences, drive innovation and drive revenue gains. efficiency at all levels of the value chain – from research and development, to manufacturing, to commercial operations. The deep integration of digital, technology and data solutions is essential to transform the practice of medicine and bring better solutions to patients.
About Sanofi
We are an innovative, global health company driven by one purpose: to pursue the miracles of science to improve people’s lives. Our teams, present in a hundred countries, are working to transform the practice of medicine to make the impossible possible. We provide therapeutic solutions that can change the lives of patients and vaccines that protect millions of people around the world, guided by the ambition of sustainable development and our social responsibility.
Sanofi is listed on EURONEXT: SAN and NASDAQ: SNY.
Media relations
Nicholas Obrist
| + 33 6 77 21 27 55 |
Kate Conway
| + 1 508 364 4931 |
Victor Rouault
| + 33 6 70 93 71 40 |
Investor Relations
Eva Schaefer-Jansen
| + 33 7 86 80 56 39 |
Arnaud Delépine
| + 33 6 73 69 36 93 |
Corentine Driancourt
| + 33 6 40 56 92 21 |
Felix Lauscher
| + 1 908 612 7239 |
Priya Nanduri
| +1 617 764 6418 |
Nathalie Pham
| + 33 7 85 93 30 17 |
Attachment
220608 GPR Sanofi Digital Accelerator EN